Use of rifabutin in treatment of systemic Mycobacterium paratuberculosis infection in mice.
BALB/c mice were infected intraperitoneally with Mycobacterium paratuberculosis and, after allowing the infection to progress for 30 days, were treated with rifabutin at 0, 12.5, 25, and 50 mg/kg of body weight. Rifabutin was administered in drinking water under conditions of water deprivation, wher...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1993
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188034/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8215277/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.8.1645 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|